Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

What Does 2019 Hold For Biopharma?

Jan 23 2019

• By Eleanor Malone and Joseph Haas

Trends — • Source: Shutterstock

Related Content

Scrip Asks… What Does 2019 Hold For Biopharma? Part 2: Business Trends

Jan 08 2019

Scrip Asks...What Does 2019 Hold For Biopharma? Part 3: Pricing, Reimbursement And Market Access

Jan 15 2019

Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advances

Dec 24 2018

Related Companies

Amarin Corp plc

Curis, Inc.

BioMarin Pharmaceutical Inc.

Spark Therapeutics, Inc.

Novartis AG

AveXis, Inc.

Genetix Biotherapeutics

Eidos Therapeutics, Inc.

AC Immune SA

Novo Nordisk A/S

Scinai Immunotherapeutics Ltd.

Novavax, Inc.

ViiV Healthcare

Sutro Biopharma, Inc.

EyePoint Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc.

Bayer AG

Boehringer Ingelheim GmbH

Additional Topics

Business Strategies Leadership Strategy C-Suite Speaks BioPharmaceutical

More from C-Suite Speaks

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window